Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Evonik Opens a New Plant in Argentina

Published: Monday, October 21, 2013
Last Updated: Monday, October 21, 2013
Bookmark and Share
With an annual capacity of over 60,000 metric tons, the new production plant will supply ready-to-use alkoxides for use as catalysts in biodiesel production from renewable raw materials.

On October 21, 2013, Evonik Industries started up a new plant for manufacturing biodiesel-production catalysts in Argentina. 

Patrik Wohlhauser, the member of the Evonik Executive Board responsible for the South America Region, spoke at the dedication ceremony, where he underscored the importance of investment in South America: "We're investing in Argentina, because we want to take advantage of the opportunities for long-term success that the South American market has to offer. As one of the world's leading providers of biodiesel-production catalysts, we wish to continue consolidating and expanding our position," Wohlhauser remarked at the plant opening. He then added, "The investment is both a clear acknowledgment of our commitment in South America, as well as part of our strategy, which we hope will allow us to participate in the region's growth." 

The new facilities will serve primarily the Argentine and Brazilian markets. Evonik located the plant on the same site as Terminal 6 S.A., which operates a large biodiesel facility. 

As Jan Van den Bergh, president of Evonik's Advanced Intermediates Business Unit, explains, "Our aim in building the plant in Puerto General San Martín in the Rosario Region—in the heart of Argentina's biodiesel industry—is to supply our South American customers with locally produced, high-quality catalysts." 

Evonik has proven expertise in the production of biodiesel catalysts, backed up by many years of experience. In 2009, the company started up a new production facility in Mobile, Alabama, USA, with a capacity of 60,000 metric tons p.a. Evonik products from this plant meet the demand for biodiesel on the North American market. Following the success of the new production technology in the United States, the same type of plant was built in Argentina. The new technology involves directly reacting alcohol with sodium hydroxide to produce alkoxides. 

Evonik already ranks among the world leaders in biodiesel catalysts—a position it also holds in South America. "The new facility in Argentina will allow us to strengthen our business, both globally and within the region," explained Weber Ferreira Porto, the regional president for South America. "Our aim here is to participate in the development of the biodiesel market, which is forecast to experience positive growth over the medium term." Evonik is a global market leader in specialty catalysts for biodiesel production. In addition to its facilities in Argentina, the company also operates production sites in Niederkassel-Lülsdorf, near Cologne, Germany, and Mobile, Alabama, USA. 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Evonik Commences Isophorone Facilities in China
Investment exceeding €100 million targets dynamic markets in Asia.
Thursday, May 22, 2014
Biotech Company Algal Scientific Receives Investment Funding
Evonik, part of an investors’ consortium that is investing more than US$3 million in Series A financing round, is investing in the startup.
Monday, April 28, 2014
Prize Awarded to New Membrane Technology from Evonik
Biogas processing considerably more efficient and environmentally friendly.
Thursday, December 05, 2013
Evonik Expanding Global Isophorone and Isophorone Diamine Capacities
New production plants to be completed in early 2014, significantly increasing the total capacities of IP and IPD.
Friday, November 15, 2013
Scientific News
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Bioreactors Ready for the Big Time
Bioreactors are passive filtration systems that can reduce nitrate losses from farm fields.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Finding Factors That Protect Against Flu
A clinical trial examining the body’s response to seasonal flu suggests new approaches for evaluating the effectiveness of seasonal flu vaccines.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!